Strophanthin refers to several cardioactive glycosides; g-strophanthin is also known as ouabain. Its historical use as a heart medicine does not establish the current status of every product. To understand its market decline, the specific preparation, country, authorisation and clinical evidence must be distinguished.
A German example: Strodival
The former ready-made medicine Strodival mr held transitional authorisation under the old regulatory regime until 2011. The end of such transitional authorisation and modern evidence requirements are relevant to the subsequent status of the substance. This does not establish a worldwide ban on every strophanthin-containing product. A ready-made medicine and an individually prescribed pharmacy preparation are legally different cases.
Legal availability does not prove efficacy
In 2024, Germany’s Federal Social Court referred a dispute over a compounded strophanthin preparation back for further examination. This was neither a new medicine authorisation nor general clinical proof of efficacy. Historical use and individual positive experiences do not replace a robust assessment of benefits and risks for a specific heart condition.
Do not equate oral and injected preparations
Different glycosides and dosage forms are not freely interchangeable. Effects on heart muscle cells or historical injection treatments do not establish safe oral self-treatment. Existing heart treatment requires medical supervision; do not replace medicines with drops, plant material or products from unclear sources.
Safety margins are narrow
Cardioactive glycosides can cause nausea, visual disturbances, confusion and dangerous heart rhythm disturbances. Electrolyte imbalances and other medicines can influence the risks. Symptoms after use need medical assessment and do not prove a desirable initial reaction. Seek immediate emergency help for chest pain, severe breathlessness, fainting or marked rhythm disturbances.
Frequently asked questions
Does the end of an old authorisation mean a worldwide substance ban?
No. The country, specific product and legal basis must be assessed separately.
Does a compounded preparation automatically prove clinical benefit?
No. Preparation and prescribing do not replace evidence of efficacy.
Can I change my heart medicines myself?
No. Changes must be agreed with a doctor.
